NASDAQ · ICCC
ImmuCell Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for ICCC: Nov 12, 2026
ImmuCell Corporation Common Stock is estimated to report earnings on 11/12/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. The reported EPS for the same quarter last year was $-0.02.
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · RTTNews · The Motley Fool · MarketBeat- Zacks · Oct 21, 10:31 AM EDTZTS vs. ICCC: Which Animal Health Stock Is the Better Investment Bet?Zoetis offers diversification and stability, while ImmuCell boasts stronger sales growth and expansion potential.
- RTTNews · Oct 13, 3:21 AM EDTImmuCell Reports Preliminary Q3 2026 Sales Growth Of 46%;Stock Up(RTTNews) – ImmuCell Corp. (ICCC), an animal health biologics company announced preliminary, unaudited sales results for the third quarter of 2026.
- Zacks · Sep 29, 2:23 AM EDTThe Zacks Analyst Blog Highlights Alphabet, Mastercard, AbbVie, Perma-Pipe and ImmuCellGOOGL, MA and ABBV headline today's research, with AI-led growth, electronic payments and strong drug portfolios shaping their outlooks.
- Zacks · Sep 28, 3:49 PM EDTTop Research Reports for Alphabet, Mastercard & AbbVieAlphabet's AI-led cycle is strengthening Search, Cloud and subscriptions, while rising investment and regulatory risks create uncertainty around returns.
- Zacks · Aug 27, 10:10 AM EDTImmuCell Stock Falls 8.8% Despite Y/Y Earnings & Sales Growth in Q2ICCC's Q2 sales rise 11.5% y/y, but margins contract. A $2-million legal settlement boosts profit as the company plans a capacity expansion.
- The Motley Fool · Aug 20, 6:45 PM EDTImmuCell (ICCC) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Aug 14, 10:04 AM EDTImmuCell Q2 Earnings Call HighlightsImmuCell (NASDAQ:ICCC) reported higher second-quarter sales and earnings as domestic demand for its calf scours prevention products increased, while the company outlined plans to invest about $8 million to more than triple manufacturing capacity by the end of 2027. Product sales
- RTTNews · Jul 13, 7:17 AM EDTBiotech Stocks At 52-Week Highs: AMWL, CUE, ICCC, SRRK, FTH(RTTNews) – The following biotech stocks touched a 52-wek high on July 10, 2026, driven by key catalysts like encouraging regulatory updates and quarterly results.
- RTTNews · Jul 10, 10:39 AM EDTImmuCell Records Q2 Sales Of $7 Mln & 20% Rise For Six-Month Sales In Preliminary Results(RTTNews) – ImmuCell Corporation (ICCC), an animal health biologics company, on Thursday announced second quarter preliminary sales results, marking a 11.55% increase primarily due to significant TriShield sales.
- Zacks · Jul 10, 9:45 AM EDTImmuCell Posts Strong Preliminary Q2 Sales on U.S. DemandICCC reports an 11.5% rise in preliminary Q2 sales, driven by robust U.S. demand and improved product availability, extending the momentum from its strong Q1 performance.
- Zacks · Jun 26, 5:26 AM EDTThe Zacks Analyst Blog Highlights JPMorgan, Novartis, Qualcomm, Genie and ImmuCellMicron surged after strong Q3 results, robust AI-driven memory demand and a bullish Q4 outlook. See which ETFs have notable exposure.
- Zacks · Jun 25, 4:33 PM EDTTop Stock Reports for JPMorgan, Novartis & QualcommJPMorgan, Novartis and Qualcomm headline today's top stock reports, highlighting growth drivers, competitive pressures and key catalysts ahead.
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for ImmuCell Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.